- Home
- STRW vs ALEC Comparison
STRW vs ALEC Comparison
Compare STRW & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRW
- ALEC
- Stock Information
- Founded
- STRW 2015
- ALEC 2013
- Country
- STRW United States
- ALEC United States
- Employees
- STRW N/A
- ALEC N/A
- Industry
- STRW Real Estate Investment Trusts
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STRW Real Estate
- ALEC Health Care
- Exchange
- STRW Nasdaq
- ALEC Nasdaq
- Market Cap
- STRW 154.1M
- ALEC 124.0M
- IPO Year
- STRW N/A
- ALEC 2019
- Fundamental
- Price
- STRW $12.28
- ALEC $2.76
- Analyst Decision
- STRW Strong Buy
- ALEC Buy
- Analyst Count
- STRW 4
- ALEC 8
- Target Price
- STRW $12.72
- ALEC $4.50
- AVG Volume (30 Days)
- STRW 25.5K
- ALEC 1.2M
- Earning Date
- STRW 11-10-2025
- ALEC 11-05-2025
- Dividend Yield
- STRW 4.55%
- ALEC N/A
- EPS Growth
- STRW 27.31
- ALEC N/A
- EPS
- STRW 0.59
- ALEC N/A
- Revenue
- STRW $135,145,000.00
- ALEC $81,130,000.00
- Revenue This Year
- STRW $33.39
- ALEC N/A
- Revenue Next Year
- STRW $5.21
- ALEC $196.86
- P/E Ratio
- STRW $20.78
- ALEC N/A
- Revenue Growth
- STRW 24.72
- ALEC 46.77
- 52 Week Low
- STRW $8.70
- ALEC $0.87
- 52 Week High
- STRW $12.90
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- STRW 53.10
- ALEC 53.77
- Support Level
- STRW N/A
- ALEC N/A
- Resistance Level
- STRW $12.08
- ALEC $3.00
- Average True Range (ATR)
- STRW 0.39
- ALEC 0.19
- MACD
- STRW -0.46
- ALEC -0.12
- Stochastic Oscillator
- STRW 96.62
- ALEC 89.90
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.